149 related articles for article (PubMed ID: 36220300)
21. "RESET" Effect: Random Extending Sequences Enhance the Trans-Cleavage Activity of CRISPR/Cas12a.
Ma JY; Wang SY; Du YC; Wang DX; Tang AN; Wang J; Kong DM
Anal Chem; 2022 Jun; 94(22):8050-8057. PubMed ID: 35615910
[TBL] [Abstract][Full Text] [Related]
22. Cas12a-based electrochemiluminescence biosensor for target amplification-free DNA detection.
Liu PF; Zhao KR; Liu ZJ; Wang L; Ye SY; Liang GX
Biosens Bioelectron; 2021 Mar; 176():112954. PubMed ID: 33412428
[TBL] [Abstract][Full Text] [Related]
23. End-point dual specific detection of nucleic acids using CRISPR/Cas12a based portable biosensor.
Wu H; Qian C; Wu C; Wang Z; Wang D; Ye Z; Ping J; Wu J; Ji F
Biosens Bioelectron; 2020 Jun; 157():112153. PubMed ID: 32250930
[TBL] [Abstract][Full Text] [Related]
24. "One-to-many" signal-output strategy-based CRISPR/Cas12a system for sensitive label-free fluorescence detection of HBV-DNA.
Liu B; Li Y; Du L; Zhang F; Liu Y; Sun J; Zhang Q; Li C; Li X; Xue Q
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jan; 304():123338. PubMed ID: 37683439
[TBL] [Abstract][Full Text] [Related]
25. Harnessing Multiplex crRNA in the CRISPR/Cas12a System Enables an Amplification-Free DNA Diagnostic Platform for ASFV Detection.
Zeng M; Ke Y; Zhuang Z; Qin C; Li LY; Sheng G; Li Z; Meng H; Ding X
Anal Chem; 2022 Aug; 94(30):10805-10812. PubMed ID: 35857897
[TBL] [Abstract][Full Text] [Related]
26. A label-free impedance biosensing assay based on CRISPR/Cas12a collateral activity for bacterial DNA detection.
Bonini A; Poma N; Vivaldi F; Biagini D; Bottai D; Tavanti A; Di Francesco F
J Pharm Biomed Anal; 2021 Sep; 204():114268. PubMed ID: 34298471
[TBL] [Abstract][Full Text] [Related]
27. A novel label-free universal biosensing platform based on CRISPR/Cas12a for biomarker detection.
Mu X; Wang X; Qin Y; Huang Y; Tian J; Zhao S
Talanta; 2023 Jan; 251():123795. PubMed ID: 35952502
[TBL] [Abstract][Full Text] [Related]
28. CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis.
Su J; Ke Y; Maboyi N; Zhi X; Yan S; Li F; Zhao B; Jia X; Song S; Ding X
Small Methods; 2021 Dec; 5(12):e2100935. PubMed ID: 34928030
[TBL] [Abstract][Full Text] [Related]
29. DNAzyme Amplified Aptasensing Platform for Ochratoxin A Detection Using a Personal Glucose Meter.
Zhang S; Luan Y; Xiong M; Zhang J; Lake R; Lu Y
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9472-9481. PubMed ID: 33550797
[TBL] [Abstract][Full Text] [Related]
30. A portable and quantitative biosensor for cadmium detection using glucometer as the point-of-use device.
Zeng L; Gong J; Rong P; Liu C; Chen J
Talanta; 2019 Jun; 198():412-416. PubMed ID: 30876580
[TBL] [Abstract][Full Text] [Related]
31. Enhanced chemiluminescence imaging sensor for ultrasensitive detection of nucleic acids based on HCR-CRISPR/Cas12a.
Ke X; Ou Y; Lin Y; Hu T
Biosens Bioelectron; 2022 Sep; 212():114428. PubMed ID: 35671698
[TBL] [Abstract][Full Text] [Related]
32. Upconversion-mediated CRISPR-Cas12a biosensing for sensitive detection of ochratoxin A.
Mao Z; Wang X; Chen R; Zhou Z; Ren S; Liang J; Gao Z
Talanta; 2022 May; 242():123232. PubMed ID: 35180538
[TBL] [Abstract][Full Text] [Related]
33. CRISPR/Cas-engineered technology: Innovative approach for biosensor development.
Zavvar TS; Khoshbin Z; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Biosens Bioelectron; 2022 Oct; 214():114501. PubMed ID: 35777218
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas12a-based efficient electrochemiluminescence biosensor for ATP detection.
Xu ZH; Zhao ZY; Wang H; Wang SM; Chen HY; Xu JJ
Anal Chim Acta; 2021 Dec; 1188():339180. PubMed ID: 34794559
[TBL] [Abstract][Full Text] [Related]
35. A boosting upconversion luminescent resonance energy transfer and biomimetic periodic chip integrated CRISPR/Cas12a biosensor for functional DNA regulated transduction of non-nucleic acid targets.
Li CY; Zheng B; Liu YH; Gao JL; Zheng MQ; Pang DW; Tang HW
Biosens Bioelectron; 2020 Dec; 169():112650. PubMed ID: 32987327
[TBL] [Abstract][Full Text] [Related]
36. Electrochemical biosensor for detecting pathogenic bacteria based on a hybridization chain reaction and CRISPR-Cas12a.
Liu X; Bu S; Feng J; Wei H; Wang Z; Li X; Zhou H; He X; Wan J
Anal Bioanal Chem; 2022 Jan; 414(2):1073-1080. PubMed ID: 34693471
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas12a-Responsive Hydrogels for Conjugation-Free and Universal Indicator Release in Colorimetric Detection.
Zhao R; Tang Y; Song D; Liu M; Li B
Anal Chem; 2023 Dec; 95(50):18522-18529. PubMed ID: 38055961
[TBL] [Abstract][Full Text] [Related]
38. Low-cost and highly efficient DNA biosensor for heavy metal ion using specific DNAzyme-modified microplate and portable glucometer-based detection mode.
Zhang J; Tang Y; Teng L; Lu M; Tang D
Biosens Bioelectron; 2015 Jun; 68():232-238. PubMed ID: 25576929
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas12a-based fluorescence immunoassay: combination of efficient signal generation with specific molecule recognition.
Li X; Zhang Y; Liu Q; Jin Y; Li B
Analyst; 2022 Aug; 147(17):3833-3837. PubMed ID: 35920723
[TBL] [Abstract][Full Text] [Related]
40. A portable CRISPR-Cas12a triggered photothermal biosensor for sensitive and visual detection of Staphylococcus aureus and Listeria monocytogenes.
Gu X; Tang Q; Kang X; Ji H; Shi X; Shi L; Pan A; Zhu Y; Jiang W; Zhang J; Liu J; Wu M; Wu L; Qin Y
Talanta; 2024 May; 271():125678. PubMed ID: 38277968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
